Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	66,896	71,140	68,075	83,782	68,950	59,843
Market Cap Growth	-7.28%	4.50%	-18.75%	21.51%	15.22%	33.09%
Enterprise Value	53,003	65,996	62,574	76,682	64,555	56,604
PE Ratio	17.44	18.61	18.58	25.26	18.88	8.77
Forward PE	15.46	17.11	15.19	19.36	17.29	11.00
PEG Ratio	-	2.93	0.95	4.75	-	-
PS Ratio	5.48	5.69	5.50	7.33	6.50	4.27
PB Ratio	2.51	2.61	2.66	3.70	3.49	3.66
P/TBV Ratio	2.24	2.68	2.79	3.85	3.61	3.78
P/FCF Ratio	19.25	19.99	21.30	24.79	17.87	10.51
P/OCF Ratio	15.78	16.39	17.66	20.92	15.77	9.69
EV/Sales Ratio	4.23	5.28	5.05	6.70	6.08	4.04
EV/EBITDA Ratio	14.16	18.36	16.04	19.68	14.57	7.03
EV/EBIT Ratio	16.38	21.15	17.98	21.73	15.62	7.26
EV/FCF Ratio	15.25	18.55	19.58	22.69	16.73	9.94
Debt / Equity Ratio	0.09	0.09	0.09	0.10	0.12	0.11
Debt / EBITDA Ratio	0.66	0.66	0.61	0.61	0.53	0.29
Debt / FCF Ratio	0.66	0.66	0.74	0.70	0.61	0.41
Net Debt / Equity Ratio	-0.19	-0.19	-0.21	-0.31	-0.22	-0.16
Net Debt / EBITDA Ratio	-1.43	-1.43	-1.41	-1.82	-0.99	-0.32
Net Debt / FCF Ratio	-1.45	-1.45	-1.72	-2.10	-1.14	-0.46
Asset Turnover	0.37	0.37	0.40	0.42	0.45	0.75
Inventory Turnover	0.67	0.67	0.70	0.73	0.72	1.26
Quick Ratio	3.28	3.28	3.86	4.82	4.16	2.98
Current Ratio	4.13	4.13	4.73	5.69	5.06	3.56
Return on Equity (ROE)	14.87%	14.87%	15.95%	16.26%	20.94%	54.21%
Return on Assets (ROA)	7.87%	7.87%	10.40%	12.23%	15.49%	36.37%
Return on Invested Capital (ROIC)	11.50%	11.50%	16.48%	20.01%	23.65%	54.51%
Return on Capital Employed (ROCE)	10.22%	10.22%	12.57%	14.52%	19.92%	49.75%
Earnings Yield	5.74%	5.37%	5.38%	3.96%	5.30%	11.40%
FCF Yield	5.20%	5.00%	4.69%	4.03%	5.60%	9.51%
Dividend Yield	0.48%	0.46%	0.00%	0.00%	0.00%	0.00%
Payout Ratio	8.22%	8.22%	0.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	4.09%	4.09%	2.78%	1.86%	1.28%	1.47%
Total Shareholder Return	4.57%	4.55%	2.78%	1.86%	1.28%	1.47%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.